92 results
Page 3 of 5
8-K
EX-99.1
fjv5e
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
424B5
u3hgd5zn53xemgntk
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-99.1
4sz42
5 Aug 21
Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.2
xw7gv9 hw
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-99.1
nms1ie6c6q fj
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.1
z75ua0d kx3q
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-99.1
8tlpq38 c1
4 May 21
Arvinas Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.1
rfut ztf0d4cyr4
1 Mar 21
Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:03pm
8-K
EX-99.1
sfj4r 6wevs
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
dt3yoekhdlxjw jmv
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
8auhg36tw
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
2svs4xpx gkev5le
14 Dec 20
Automatic shelf registration
4:02pm
8-K
EX-99.1
t1jdzpuw
14 Dec 20
Regulation FD Disclosure
7:30am
8-K
EX-99.2
09hw7a
14 Dec 20
Regulation FD Disclosure
7:30am
8-K
EX-99.1
61cr7g
5 Nov 20
Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:31am